Commerce Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Sell |
4,536
-21
| -0.5% | -$6.85K | 0.01% | 550 |
|
|
2025
Q1 | $1.23M | Buy |
4,557
+55
| +1% | +$14.9K | 0.01% | 576 |
|
|
2024
Q4 | $1.06M | Sell |
4,502
-20
| -0.4% | -$4.71K | 0.01% | 618 |
|
|
2024
Q3 | $1.24M | Sell |
4,522
-95
| -2% | -$26.1K | 0.01% | 588 |
|
|
2024
Q2 | $1.12M | Sell |
4,617
-39
| -0.8% | -$9.48K | 0.01% | 597 |
|
|
2024
Q1 | $696K | Sell |
4,656
-27
| -0.6% | -$4.04K | ﹤0.01% | 739 |
|
|
2023
Q4 | $896K | Buy |
4,683
+77
| +2% | +$14.7K | 0.01% | 641 |
|
|
2023
Q3 | $816K | Buy |
4,606
+28
| +0.6% | +$4.96K | 0.01% | 628 |
|
|
2023
Q2 | $870K | Sell |
4,578
-30
| -0.7% | -$5.7K | 0.01% | 612 |
|
|
2023
Q1 | $923K | Buy |
4,608
+158
| +4% | +$31.7K | 0.01% | 582 |
|
|
2022
Q4 | $1.06M | Sell |
4,450
-27
| -0.6% | -$6.42K | 0.01% | 547 |
|
|
2022
Q3 | $896K | Sell |
4,477
-20,170
| -82% | -$4.04M | 0.01% | 572 |
|
|
2022
Q2 | $3.6M | Buy |
24,647
+20,289
| +466% | +$2.96M | 0.03% | 335 |
|
|
2022
Q1 | $712K | Buy |
4,358
+100
| +2% | +$16.3K | ﹤0.01% | 689 |
|
|
2021
Q4 | $722K | Buy |
4,258
+21
| +0.5% | +$3.56K | ﹤0.01% | 722 |
|
|
2021
Q3 | $800K | Sell |
4,237
-1,604
| -27% | -$303K | 0.01% | 678 |
|
|
2021
Q2 | $990K | Buy |
5,841
+53
| +0.9% | +$8.98K | 0.01% | 614 |
|
|
2021
Q1 | $817K | Sell |
5,788
-33,798
| -85% | -$4.77M | 0.01% | 653 |
|
|
2020
Q4 | $5.15M | Buy |
39,586
+5,051
| +15% | +$656K | 0.04% | 298 |
|
|
2020
Q3 | $5.03M | Buy |
34,535
+3,267
| +10% | +$476K | 0.05% | 264 |
|
|
2020
Q2 | $4.63M | Buy |
31,268
+26,788
| +598% | +$3.97M | 0.05% | 265 |
|
|
2020
Q1 | $488K | Buy |
4,480
+1,390
| +45% | +$151K | 0.01% | 593 |
|
|
2019
Q4 | $356K | Buy |
+3,090
| New | +$356K | ﹤0.01% | 768 |
|